Enteric fever: Difference between revisions

From IDWiki
m ()
(added doses)
 
Line 48: Line 48:
**Can take 4 to 6 days to defervesce, even with treatment
**Can take 4 to 6 days to defervesce, even with treatment
*Monitor for relapse 2 to 3 weeks after treatment ends
*Monitor for relapse 2 to 3 weeks after treatment ends
{| class="wikitable"

!Antibiotic
!Dose
!Duration
|-
|[[azithromycin]]
|1 g p.o. once followed by 500 mg p.o. daily, or
1 g p.o. daily
|5 to 7 days
|-
|[[ciprofloxacin]]
|500 mg p.o. twice daily
| rowspan="2" |7 to 10 days
|-
|[[ofloxacin]]
|400 mg p.o. twice daily
|-
|[[ceftriaxone]]
|2 g IV daily
| rowspan="6" |10 to 14 days
|-
|[[cefotaxime]]
|1 to 2 g IV every 6 to 8 hours
|-
|[[cefixime]]
|200 mg p.o. twice daily
|-
|[[meropenem]]
|1 to 2 IV every 8 hours
|-
|[[TMP-SMX]]
|1 DS tablet p.o. twice daily
|-
|[[amoxicillin]]
|1 g p.o. three times daily
|-
|[[chlormaphenicol]]
|500 tp 750 mg p.o. four times daily
|14 to 21 days
|}
[[Category:Gram-negative bacilli]]
[[Category:Gram-negative bacilli]]
[[Category:Returned travellers]]
[[Category:Returned travellers]]

Latest revision as of 14:59, 13 May 2024

Background

Microbiology

  • Caused by Salmonella enterica subspecies enterica serotypes Typhi and Paratyphi
  • Virulence is related to Vi antigen and invasin protein

Epidemiology

  • Fecal-oral transmission acquired from contaminated food, milk, or water
  • Less than 5% of infected people become chronic carriers, with bacteria remaining in the gallbladder despite adequate antibiotic treatment

Pathophysiology

  • Induction of pH-shock proteins and other adaptions allow ingested bacteria to pass through the stomach and into the small intestine
  • There, they penetrate the intestinal mucosa followed by mononuclear cells, which transport them to lymph nodes
  • They multiple within the reticuloendothelial system during the incubation period
  • After a threshold is reached, they disseminate to blood

Clinical Manifestations

Diagnosis

  • Blood cultures (large volume, like x4), stool cultures, bone marrow biopsy (most sensitive)

Management

  • Treatment with third-generation cephalosporins like ceftriaxone, stepped down to oral when improving and susceptibility data are available
  • Duration 10 to 14 days
    • Can take 4 to 6 days to defervesce, even with treatment
  • Monitor for relapse 2 to 3 weeks after treatment ends
Antibiotic Dose Duration
azithromycin 1 g p.o. once followed by 500 mg p.o. daily, or

1 g p.o. daily

5 to 7 days
ciprofloxacin 500 mg p.o. twice daily 7 to 10 days
ofloxacin 400 mg p.o. twice daily
ceftriaxone 2 g IV daily 10 to 14 days
cefotaxime 1 to 2 g IV every 6 to 8 hours
cefixime 200 mg p.o. twice daily
meropenem 1 to 2 IV every 8 hours
TMP-SMX 1 DS tablet p.o. twice daily
amoxicillin 1 g p.o. three times daily
chlormaphenicol 500 tp 750 mg p.o. four times daily 14 to 21 days